drugset / Trial / NCT00601965
Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults
Completed
73 enrolled
Veterans Medical Research Foundation
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will assess whether adding cognitive behavioral therapy to the antidepressant escitalopram is effective in reducing anxiety in older adults with generalized anxiety disorder.
Timeline
- Start
- 2007-10
- Primary completion
- 2011-09
- Completion
- 2011-09
Outcome
Met primary endpoint
paper Both escitalopram and CBT prevented relapse compared with placebo. PMID 23680817 ↗
registry MEAN Escitalopram + CBT: 52.8 (Standard Deviation 2.6) units on a scale NCT00601965 ↗
registry Escitalopram + CBT vs Escitalopram + no CBT vs Placebo + CBT vs Placebo + no CBT; p = 0.01; Mixed Models Analysis NCT00601965 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 20 mg | Oral |